Neurodegenerative Disorders:

These are conditions characterised by the progressive degeneration of brain or spinal cord neurons. Examples include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).

...

Stroke and Vascular Disorders:

Health issues related to the flow of blood and the functioning of blood vessels in the brain, including ischemic stroke, hemorrhagic stroke, transient ischemic attacks (TIAs), and cerebral vasculitis.

...

Epilepsy and Seizure Disorders:

Abnormal electrical activity in the brain causes seizures and includes epilepsy and other disorders.

...

Headache issues:

Conditions characterized by recurrent headaches, including migraines, tension-type headaches, and cluster headaches.

...

Multiple Sclerosis and Demyelinating Disorders:

Disorders that cause neurological symptoms when the immune system targets the myelin sheath that encases nerve fibres. The most well-known example is multiple sclerosis.

...

Movement Disorders:

Conditions affecting movement control, including Parkinson's disease, essential tremor, dystonia, and restless legs syndrome.

...

Neuromuscular Disorders:

Conditions affecting the nerves that control voluntary muscles, including muscular dystrophy, myasthenia gravis, peripheral neuropathy, and Charcot-Marie-Tooth disease.

...

Neurodevelopmental Disorders:

Conditions that affect brain development and function, such as autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), and intellectual disabilities.

...

Neuro-Oncology

Illnesses that involve central nervous system tumours, such as spinal cord and brain tumours.

...

Neuroinflammatory Disorders:

Conditions characterized by inflammation of the nervous system, such as meningitis, encephalitis, and autoimmune disorders like Guillain-Barré syndrome.

...

Gene Therapy for Neurological Disorders

Gene therapy holds promise for treating certain neurological conditions by targeting the underlying genetic causes, like spinal muscular atrophy (SMA) and certain types of inherited neuropathies. Approvals for gene therapies and ongoing clinical trials are exploring their effectiveness in treating various neurological disorders.

...

Biological Therapies for Multiple Sclerosis (MS):

Biological therapies, such as monoclonal antibodies targeting specific immune cells or proteins involved in MS pathology, have revolutionised the treatment landscape for MS. These medications aim to reduce disease activity, slow progression, and improve symptoms in individuals with relapsing-remitting MS and, in some cases, progressive forms of the disease.

...

Neurostimulation Therapies:

Neurostimulation techniques, including deep brain stimulation (DBS), vagus nerve stimulation (VNS), and transcranial magnetic stimulation (TMS), are increasingly used to manage various neurological conditions. These therapies modulate neuronal activity and hold promise for treating disorders such as Parkinson's disease, epilepsy, depression, and chronic pain.

...

Immunotherapies for Neurological Autoimmune Disorders:

Immunotherapies, including intravenous immunoglobulin (IVIG), plasma exchange (plasmapheresis), and monoclonal antibodies targeting specific immune pathways, are used to manage autoimmune disorders affecting the nervous system, like Guillain-Barré syndrome, myasthenia gravis, and autoimmune encephalitis.

...

Advancements in Stroke Treatment

Recent advancements in acute stroke treatment include the widespread adoption of mechanical thrombectomy for large vessel occlusions and the use of neuroprotective agents to minimise brain injury during ischemic stroke. Additionally, research continues on neurorehabilitation strategies to improve the quality of life for stroke survivors.

...

Precision Medicine Approaches:

Advances in genomics, proteomics, and other -omics technologies are facilitating the development of personalised treatment approaches in neurology. Precision medicine tailor's treatments based on individual genetic makeup, biomarker profiles, and disease characteristics, resulting in more effective and targeted therapies for neurological disorders.

...

Novel Therapies for Neurodegenerative Diseases:

Research efforts are ongoing to identify disease-modifying therapies for neurodegenerative illnesses, such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). This includes investigational drugs targeting protein aggregation, neuroinflammation, mitochondrial dysfunction, and other pathological mechanisms implicated in these disorders.

...

Telemedicine and Digital Health Solutions:

Telemedicine and digital health platforms are increasingly used in neurology to facilitate remote consultations, monitor disease progression, deliver cognitive-behavioral therapies, and support patient self-management. These technologies improve access to care, enhance patient-provider communication, and enable more comprehensive disease management.

...